Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1912345...10...Last »

Ironshore Laid Off Staff, Quietly Closed Down

Almost one year after filing a New Drug Application for an ADHD drug and less than one year after announcing it secured $200 million in financing, Ironshore Pharmaceuticals closed its doors.

Read More »

Publicis Health Appoints Michael du Toit as Chief Growth Officer for Communications & Media

Mr. du Toit is responsible for leading Publicis Health’s global business development strategy.

Read More »

Novartis Lands New Oncology Head

Novartis hired Elizabeth Barrett, Pfizer’s head of oncology, to replace Bruno Strigini, the chief executive officer of Novartis Oncology who retired at the end of 2017.

Read More »

McCann Health Names Global Chief Digital Officer

McCann Health announced the appointment of Marcus Sigurdsson to the new position of Global Chief Digital Officer.

Read More »

GlaxoSmithKline CEO Replaced 50 Top Managers, Lured Execs From Google, Novartis and Teva

GlaxoSmithKline Chief Executive Officer Emma Walmsley continues to overhaul the company’s pharmaceutical division. Since assuming GSK’s helm, Walmsley has replaced about 50 of its top managers.

Read More »

OvaScience Pinks Slips Nearly 50 Percent of Workforce

OvaScience is restructuring to cut costs. As part of that process, the company is laying off about half of its staff.

Read More »

New SoCal Biotech Launches With $55.3 Million Backed by Novartis, Sanofi and 5AM Ventures

Expansion Therapeutics officially launched with the close of a $55.3 million Series A financing.

Read More »

Intouch Solutions Promotes Five Chicago Employees

Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, announced the promotion of five employees in its Chicago office.

Read More »

265 Employees Affected as San Diego’s Dart NeuroScience Decides to Close Its Doors

Privately held Dart NeuroScience and its quest to develop therapies intended to improve cognitive vitality will close its doors on Feb. 9, 2018, due to poor progress on the San Diego-based company’s therapeutic goals and little return on hundreds of millions of dollars in research and development.

Read More »

Intouch Solutions Advances Strategic Planning and Client Services Offerings with Leadership Promotions

Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, announced several leadership promotions.

Read More »

Diane Iler-Smith Joins Biolumina as SVP, Executive Creative Director

Diane Iler-Smith has returned to Biolumina as SVP, Executive Creative Director. Biolumina is a full-service, integrated agency delivering omnichannel solutions for the pharmaceutical industry

Read More »

Israel’s Protalix to Slash 20 Percent of Workforce

Share prices for Protalix Biotherapeutics were up more than 3 percent this morning after the company reported positive results from its Phase I/II open label extension trial of pegunigalsidase alfa, PRX-102, for the treatment of Fabry disease. Despite that positive news on its pipeline, Protalix is reportedly set to terminate 50 employees, which amounts to about 20 percent of its workforce.

Read More »

Teva Announces New Organization Structure

Teva Pharmaceutical Industries announced a new organization and leadership structure aimed to achieve better commercial focus and drive value creation.

Read More »

Ardelyx to Ditch Phase III Hyperkalemia Drug

Ardelyx decided to shutter development of RDX7675 – an experimental medicine for hyperkalemia – including the onset-of-action trial and Phase III studies.

Read More »

Life Science Giant PPD Cuts an Undisclosed Number of Jobs

CRO giant Pharmaceutical Product Development LLC terminated a number of employees in its human resources department, but has provided few details about the job cuts, according to reports.

Read More »

W2O Group Expands Chicago Presence

W2O Group, a network of innovative analytics-driven, digital-first marketing and communications firms, announced the appointment of three senior executives in its growing Chicago office.

Read More »

GSK appoints new R&D head

GlaxoSmithKline poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head.

Read More »

Mario Muredda Named CEO of Harrison and Star

Omnicom Health Group announced that Mario Muredda has been named CEO of Harrison and Star and former CEO Ty Curran has been promoted to chairman. The changes are effective January 1, 2018.

Read More »

Kirsten A. Kantak Appointed CEO of Biolumina

Omnicom Health Group announced that Kirsten A. Kantak was appointed CEO of Biolumina.

Read More »

X-Spine Systems to Shut Down, Lays Off 54 Employees

X-Spine Systems, a division of Xtant Medical Systems, is shutting down a facility in Ohio and terminating 54 people between December and February 2018.

Read More »

Page 1 of 1912345...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2017 Focus: Ad Agency Roundtable and more!


Ad Right Bottom

Main Navigation